$4.58
0.071.55%
At Close: -
$4.58
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
MaxCyte reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of MaxCyte using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
MXCT | MaxCyte | -$0.10 | -$0.13 | — | — | $9.04M | $7.92M | — | — | 08/06/2024 | Get Alert |
MXCT | MaxCyte | -$0.11 | -$0.13 | -$0.09 | 30.77% | $8.58M | $7.46M | $11.34M | 52.04% | 05/07/2024 | Get Alert |
MXCT | MaxCyte | -$0.05 | -$0.07 | -$0.05 | 28.57% | $12.42M | $13.09M | $15.67M | 19.68% | 03/12/2024 | Get Alert |
MXCT | MaxCyte | -$0.06 | -$0.10 | -$0.11 | -10.00% | $10.64M | $9.77M | $8.01M | -18.07% | 11/08/2023 | Get Alert |
MXCT | MaxCyte | -$0.08 | -$0.10 | -$0.10 | 0.00% | $9.61M | $10.80M | $9.04M | -16.27% | 08/09/2023 | Get Alert |
MXCT | MaxCyte | -$0.04 | -$0.11 | -$0.11 | 0.00% | $11.59M | $8.32M | $8.58M | 3.08% | 05/10/2023 | Get Alert |
MXCT | MaxCyte | -$0.05 | -$0.07 | -$0.05 | 28.57% | $10.15M | $12.90M | $12.42M | -3.69% | 03/15/2023 | Get Alert |
MXCT | MaxCyte | -$0.03 | -$0.09 | -$0.06 | 33.33% | $10.14M | $10.43M | $10.64M | 2.04% | 11/09/2022 | Get Alert |
MXCT | MaxCyte | -$0.05 | -$0.08 | -$0.08 | 0.00% | $7.11M | $9.22M | $9.61M | 4.21% | 08/10/2022 | Get Alert |
MXCT | MaxCyte | -$0.09 | -$0.07 | -$0.04 | 42.86% | $6.50M | $8.46M | $11.59M | 36.96% | 05/09/2022 | Get Alert |
MXCT | MaxCyte | -$0.03 | -$0.05 | -$0.05 | 0.00% | $8.51M | $9.45M | $10.15M | 7.43% | 03/22/2022 | Get Alert |
MXCT | MaxCyte | -$0.04 | -$0.05 | -$0.03 | 40.00% | — | $7.37M | $10.14M | 37.57% | 11/10/2021 | Get Alert |
MXCT | MaxCyte | -$0.05 | -$0.05 | -$0.05 | 0.00% | $5.20M | $5.95M | $7.11M | 19.46% | 09/13/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $-0.09 | $-0.13 | 30.8 % |
Dec 2023 | 2024-03-12 | $-0.05 | $-0.07 | 28.6 % |
Sep 2023 | 2023-11-08 | $-0.11 | $-0.10 | -10.0 % |
Jun 2023 | 2023-08-09 | $-0.10 | $-0.10 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $11.34M | $7.46M | 52.0 % |
Dec 2023 | 2024-03-12 | $15.67M | $13.09M | 19.7 % |
Sep 2023 | 2023-11-08 | $8.01M | $9.77M | -18.1 % |
Jun 2023 | 2023-08-09 | $9.04M | $10.80M | -16.3 % |
MaxCyte (MXCT) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
The Actual EPS was $-0.09, which beat the estimate of $-0.13.
The Actual Revenue was $11.3M, which beat the estimate of $7.5M.
Browse earnings estimates, EPS, and revenue on all stocks.